Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study.

Juan Ignacio Arraras,Jose Juan Illarramendi,Ana Manterola,Susana de la Cruz,Uxue Zarandona,Berta Ibañez,Esteban Salgado,Ignacio Visus,Marta Barrado, Lucia Teiejira, María Isabel Martinez,Enrique Martinez,Ruth Vera

Menopause (New York, N.Y.)（2023）

Cited 0|Views10

No score

Abstract

The results of this study show that postmenopausal early-stage breast cancer patients adapted well to their disease and endocrine therapy treatment. QOL improvements in the 1-year follow-up period appeared in one key area: pain. Differences between endocrine therapy modalities suggested QOL was better in the tamoxifen group than in the AI group.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined